Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens

NCT02505243 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02505243
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02505243 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of RIBAvirin Plasma COncentrations in Patients With Chronic Hepatitis C Infection Routinely Treated With Modern DAA Regimens
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
June 30, 2016
Enrollment
252 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hcv coinfection, hepatitis c